References
- Barlev N A, Liu L, Chehab N H, Mansfield K, Harris K G, Halazonetis T D, Berger S L. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Molecular Cell 2001; 8: 1243–1254
- Chalk A M, Sonnhammer E L. Computational antisense oligo prediction with a neural network model. Bioinformatics 2002; 18: 1567–1575
- Cheng H L, Mostoslavsky R, Saito S, Manis J P, Gu Y, Patel P, Bronson R, Appella E, Alt F W, Chua K F. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 10794–10799
- Du N, Feng K, Luo C, Li L, Bai C, Pei X. Radioprotective effect of FLT3 ligand expression regulated by Egr-1 regulated element on radiation injury of SCID mice. Experimental Hematology 2003; 31: 191–196
- Ford J, Jiang M, Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Research 2005; 65: 10457–10463
- Feng L, Lin T, Uranishi H, Gu W, Xu Y. Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Molecular and Cellular Biology 2005; 25: 5389–5395
- Gottlieb T, Oren M. p53 in growth control and neoplasia. Biochimica Biophysica Acta 1996; 1287: 77–102
- Gu W, Roeder R G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997; 90: 595–606
- Gudkov A V, Komarova E A. The role of p53 in determining sensitivity to radiotherapy. Nature reviews/Cancer 2003; 3: 117–128
- Guo W F, Lin R X, Huang J, Zhou Z, Yang J, Guo G Z, Wang S Q. Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiation Research 2005; 164: 27–35
- Hsieh S C, Lo P K, Wang F F. Mouse DDA3 gene is a direct transcriptional target of p53 and p73. Oncogene 2002; 21: 3050–3057
- Ito A, Lai C -H, Zhao X, Saito S, Hamilton M H, Appella E, Yao T P. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO Journal 2001; 20: 1331–1340
- Ko L J, Prives C. p53: Puzzle and paradigm. Genes & Development 1996; 10: 1054–1072
- Levine A J. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323–331
- Liu L, Scolnick M, Trievel R C, Zhang H B, Marmorstein R, Halazonetis T D, Berger S L. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Molecular and Cellular Biology 1999; 19: 1202–1209
- Lu X, Lane D P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes?. Cell 1993; 75: 765–778
- Maity A, Mckenna G, Muschel R. The molecular basis for cell cycle delays following ionizing radiation: A review. Radiotherapy and Oncology 1994; 31: 1–13
- Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld J L, Deeg H J. Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology Biology Physics 1995; 31: 1319–1339
- Nayak V, Devi P U. Protection of mouse bone marrow against radiation-induced chromosome damage and stem cell death by the ocimum flavonoids orientin and vicenin. Radiation Research 2005; 163: 165–171
- Neta R, Okunieff P. Cytokine-induced radiation protection and sensitization. Seminara in Radiotherapy and Oncology 1996; 6: 306–320
- Sakaguchi K, Herrera J E, Saito S, Miki T, Bustin M, Vassilev A, Anderson C W, Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes & Development 1998; 12: 2831–2841
- Vaziri H, Dessain S K, Eaton E N, Imai S -I, Frye R A, Pandita T K, Guarente L, Weinberg R A. hSIR2SIRT1 functions as an NAD-Dependent p53 Deacetylase. Cell 2001; 107: 149–159
- Vermeulen K, Bockstaele V DR, Berneman Z N. The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferation 2003; 36: 131–149